|
HC (Mean±SEM/ n)/ Median (25%, 75%Q) |
TA (Mean±SEM/ n)/ Median
(25%, 75%Q) |
p-value |
Active (Mean±SEM/ n)/ Median (25%,
75%Q) |
Inactive (Mean±SEM/ n)/ Median (25%, 75%Q) |
p-value |
Untreated (Mean±SEM/ n)/ Median (25%, 75%Q) |
Treated (Mean±SEM/ n)/
Median (25%, 75%Q) |
p-value |
Female |
136/154 |
178/190 |
0.12 |
44/47 |
134/143 |
0.983 |
27/29 |
151/161 |
0.889 |
Age (years) |
38.05±9.07 |
36.03±12.70 |
0.620 |
35.79±12.06 |
36.11±12.94 |
0.972 |
35.17±12.45 |
35.47±12.70 |
0.259 |
Constitutional symptoms |
|
|
|
|
|
|
|
|
|
Fever |
/ |
8/190 |
/ |
3/47 |
5/143 |
0.663 |
3/29 |
5/161 |
0.199 |
Malaise |
/ |
135/190 |
/ |
34/47 |
101/143 |
0.822 |
19/29 |
116/161 |
0.475 |
Arthralgia/ Arthritis |
/ |
12/190 |
/ |
2/47 |
10/143 |
0.746 |
3/29 |
9/161 |
0.579 |
Headache |
/ |
91/190 |
/ |
20/47 |
71/143 |
0.398 |
13/29 |
78/161 |
0.719 |
Chest distress/pain |
/ |
52/190 |
/ |
14/47 |
38/143 |
0.668 |
7/29 |
45/161 |
0.672 |
Carotidynia |
/ |
16/190 |
/ |
3/47 |
13/143 |
0.782 |
1/29 |
15/161 |
0.494 |
Vascular findings |
|
|
|
|
|
|
|
|
|
Claudication |
/ |
15/190 |
/ |
8/47 |
7/143 |
0.018 |
5/29 |
10/161 |
0.098 |
Bruits |
/ |
127/190 |
/ |
30/47 |
97/143 |
0.613 |
17/29 |
110/161 |
0.307 |
Pulsation weakened |
/ |
143/190 |
/ |
34/47 |
109/143 |
0.592 |
21/29 |
122/161 |
0.699 |
Pulse deficit |
/ |
58/190 |
/ |
11/47 |
47/143 |
0.222 |
5/29 |
53/161 |
0.091 |
Asymmetric BP |
/ |
104/190 |
/ |
23/47 |
81/143 |
0.357 |
14/29 |
90/161 |
0.448 |
Hypertension |
/ |
90/190 |
/ |
27/47 |
63/143 |
0.111 |
21/29 |
69/161 |
0.003 |
Laboratory data |
|
|
|
|
|
|
|
|
|
ALT (U/L) |
14.40 (9.00-19.00) |
21.39 (11.00-24.00) |
0.002 |
19.57 (9.00-20.00) |
21.99 (11.00-26.00) |
0.135 |
22.83 (9.50-21.50) |
21.13 (11.00-24.50) |
0.864 |
Scr (μmol/L) |
59.88 (52.50-68.20) |
54.62 (46.75-61.28) |
<0.0001 |
54.51 (44.70-63.30) |
54.66
(47.20-60.70) |
0.966 |
54.18 (43.60-60.50) |
54.70 (46.95-61.50) |
0.797 |
WBC (109/L) |
5.59 (4.26-6.30) |
7.24 (4.91-8.40) |
<0.0001 |
7.40 (5.68-8.11) |
7.19 (4.71-8.50) |
0.406 |
6.05 (4.90-7.02) |
7.46 (4.91-8.72) |
0.064 |
Hb (g/L) |
133.99 (125.00-138.00) |
123.30 (114.75-133.00) |
<0.0001 |
120.45±14.41 |
124.24±14.67 |
0.088 |
124.17 (113.00-134.50) |
123.15 (114.50-131.50) |
0.380 |
PLT (109/L) |
257.17 (216.00-300.00) |
238.02
(193.75-278.25) |
0.004 |
264.55±80.61 |
229.30±60.49 |
0.011 |
246.21±78.13 |
236.55±65.63 |
0.734 |
ESR (mm/hour) |
5.58 (3.00-8.00) |
10.00 (3.00-12.00) |
0.001 |
19.66 (10.00-23.00) |
6.80 (2.00-9.00) |
<0.0001 |
13.86 (8.00-15.50) |
9.27
(2.00-11.00) |
0.001 |
hs-CRP (mg/L) |
0.90 (0.37-1.03) |
3.74 (0.13-2.29) |
0.283 |
9.49
(1.15-14.88) |
1.85 (0.08-1.17) |
<0.0001 |
6.40 (0.46-8.64) |
3.26 (0.10-2.08) |
0.001 |
C1q (mg/L) |
150.11 (143.73-158.30) |
166.85 (140.70-185.93) |
<0.0001 |
190.71 (168.10-209.90) |
159.00
(135.60-178.30) |
<0.0001 |
187.51
(164.20-212.45) |
163.12 (136.70-181.65) |
0.001 |
Numano subtypes |
|
|
|
|
|
|
|
|
|
I |
/ |
9/190 |
/ |
3/47 |
6/143 |
0.829 |
1/29 |
8/161 |
0.723 |
IIa |
/ |
4/190 |
/ |
4/47 |
0/143 |
0.003 |
0/29 |
4/161 |
0.513 |
IIb |
/ |
36/190 |
/ |
6/47 |
30/143 |
0.213 |
2/29 |
34/161 |
0.072 |
III |
/ |
7/190 |
/ |
3/47 |
4/143 |
0.493 |
2/29 |
5/161 |
0.644 |
IV |
/ |
17/190 |
/ |
3/47 |
14/143 |
0.678 |
2/29 |
15/161 |
0.947 |
V |
/ |
117/190 |
/ |
28/47 |
89/143 |
0.745 |
22/29 |
95/161 |
0.086 |